Ethan Sarnoski, PhD, is the National Institute on Aging’s Senior Program Advisor for the Development and Testing of Interventions Targeting Aging Mechanisms. He provides guidance to extramural scientists and industry drug developers on effective strategies to translate aging research into medicine, including indication selection, R&D plan, and competitive analysis. Ethan has previously served as an advisor to leading life sciences and pharmaceutical companies, and supported drug development programs through multiple successful preclinical phase transitions. He completed his PhD in Molecular, Cellular, and Developmental Biology at Yale University.